In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Hot Line V - Coronary artery disease and atrial fibrillation

ESC Congress 2014, Barcelona - press conference

Date & Time:  Tuesday 02 September, 08:00-09:00
Refers to session: Hot Line V - Coronary artery disease and atrial fibrillation

Chairpersons
Prof. Keith Fox (UK)
Prof. Freek Verheught (Netherlands)
Spokespersons
Prof. Jur Ten Berg (Netherlands)
Prof. Paulus Kirchhof (UK)

 



Perioperative statin treatment in cardiac surgery for the prevention of atrial fibrillation and perioperative myocardial damage: the Statin Therapy In Cardiac Surgery (STICS) Trial

Prof. Barbara Casadei, University of Oxford (Oxford, UK)
Press release  |  Slides 

 

The X-VERT Trial: A comparison of oral rivaroxaban once daily with dose-adjusted Vitamin K Antagonists in patients with nonvalvular atrial fibrillation undergoing elective cardioversion

Dr Ricardo Cappato, Irccs Policlinico San Donato (Italy)
Press release  |  Slides

 

Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: A double-blind, randomized, placebo-controlled study (AMIOCAT trial)

Dr Stine Darkner, Righshospitalet (Denmark)
Press release  |  Slides

 

Effect of high-intensity statin therapy on atherosclerosis in patients with ST-elevation myocardial infarction: Results of the prospective, longitudinal intravascular ultrasound follow-up study (IBIS-4 trial)

Dr Lorenz Räber, Bern Hospital University (Bern, Switzerland)
Press release  |  Slides

 

IMPI Steroid Study: A Trial of Adjunctive Prednisolone in Tuberculous Pericarditis

Prof. Bongani M. Mayosi, University of Capetown (Capetown, South Africa)
Press release  |  Slides 

 



Abstracts linked to ESC press conferences are not available until embargo lifts. The embargo lifts at the beginning of the press conference or the scientific session, whichever comes first. All other abstracts will be online on 22 August, 2014 in the Scientific Programme Planner except for Hot Lines, Clinical Trial Update and Registries Hot Lines abstracts.
Press releases are available on site in the press kit (USB key) that you will receive once you pick up your badge at the press registration desk at ESC Congress 2014 - except for press releases on Clinical Trial Updates and Hot Line sessions which are only available when the embargo lifts.
Press slides will be available at the beginning of the press conference.
All ESC Press conferences will be broadcasted live. Unfortunately, no webcast will be available. Access to the session will be restricted to registered press only.
During the ESC Congress 2014, all scientific resources are available on ESC Congress 365.